Literature DB >> 17537648

Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX.

Stephen M Smith1, Anil Rao, Nicola De Stefano, Mark Jenkinson, Jonathan M Schott, Paul M Matthews, Nick C Fox.   

Abstract

Brain volume loss (atrophy) is widely used as a marker of disease progression. Atrophy has been measured with a variety of methods, some estimating atrophy rate from two temporally separated scans, and others estimating atrophy state from a single scan. Three popular tools for measuring brain atrophy are BSI and SIENA (rate) and SIENAX (state). Previous papers have shown BSI and SIENA to have similar accuracy, but no work has carefully compared both methods using the same data set. Here we compare these methods, using data from patients with Alzheimer's disease and age-matched controls. We also compare the SIENA longitudinal measure with atrophy state estimated by SIENAX using just the earliest scan taken from each subject. We show strong correspondence and similar sensitivity to atrophy between all 3 measures.

Entities:  

Mesh:

Year:  2007        PMID: 17537648     DOI: 10.1016/j.neuroimage.2007.04.035

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  47 in total

1.  Structural imaging markers for therapeutic trials in Alzheimer's disease.

Authors:  N C Fox; J Kennedy
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

2.  Resistance training and executive functions: a 12-month randomized controlled trial.

Authors:  Teresa Liu-Ambrose; Lindsay S Nagamatsu; Peter Graf; B Lynn Beattie; Maureen C Ashe; Todd C Handy
Journal:  Arch Intern Med       Date:  2010-01-25

3.  An open source multivariate framework for n-tissue segmentation with evaluation on public data.

Authors:  Brian B Avants; Nicholas J Tustison; Jue Wu; Philip A Cook; James C Gee
Journal:  Neuroinformatics       Date:  2011-12

4.  A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease.

Authors:  S Salloway; R Sperling; R Keren; A P Porsteinsson; C H van Dyck; P N Tariot; S Gilman; D Arnold; S Abushakra; C Hernandez; G Crans; E Liang; G Quinn; M Bairu; A Pastrak; J M Cedarbaum
Journal:  Neurology       Date:  2011-09-14       Impact factor: 9.910

5.  Post-acquisition processing confounds in brain volumetric quantification of white matter hyperintensities.

Authors:  Ahmed A Bahrani; Omar M Al-Janabi; Erin L Abner; Shoshana H Bardach; Richard J Kryscio; Donna M Wilcock; Charles D Smith; Gregory A Jicha
Journal:  J Neurosci Methods       Date:  2019-08-10       Impact factor: 2.390

6.  Cerebral atrophy after traumatic white matter injury: correlation with acute neuroimaging and outcome.

Authors:  Kan Ding; Carlos Marquez de la Plata; Jun Yi Wang; Marysa Mumphrey; Carol Moore; Caryn Harper; Christopher J Madden; Roderick McColl; Anthony Whittemore; Michael D Devous; Ramon Diaz-Arrastia
Journal:  J Neurotrauma       Date:  2008-12       Impact factor: 5.269

7.  Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA/FSL.

Authors:  Roland Opfer; Ann-Christin Ostwaldt; Christine Walker-Egger; Praveena Manogaran; Maria Pia Sormani; Nicola De Stefano; Sven Schippling
Journal:  J Neurol       Date:  2018-03-16       Impact factor: 4.849

8.  MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease.

Authors:  Caroline K Jurgens; Radu Jasinschi; Ahmet Ekin; Marie-Noëlle W Witjes-Ané; Huub Middelkoop; Jeroen van der Grond; Raymund A C Roos
Journal:  PLoS Curr       Date:  2010-09-08

9.  Magnetization transfer imaging in 'premanifest' Huntington's disease.

Authors:  Caroline K Jurgens; Reineke Bos; Jasper Luyendijk; Marie-Noëlle W Witjes-Ané; Jeroen van der Grond; Huub A M Middelkoop; Raymund A C Roos
Journal:  J Neurol       Date:  2009-10-13       Impact factor: 4.849

10.  Parallel imaging: is GRAPPA a useful acquisition tool for MR imaging intended for volumetric brain analysis?

Authors:  Terri L Lindholm; Lisa Botes; Eva-Lena Engman; Anders Frank; Tomas Jonsson; Leif Svensson; Per Julin
Journal:  BMC Med Imaging       Date:  2009-08-03       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.